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論文の要旨 
Abstract of thesis 
 
Background: Mast cells (MCs) degranulation is the central cellular event involved in the effector phase of allergic 
responses. Although various stimuli can induce MCs degranulation, antigen and antigen-specific IgE mediated MCs 
degranulation through FcεRI is the most common cause of MCs activation in allergic patients. Therefore, the 
identification of novel regulatory mechanism of FcεRI-mediated MCs degranulation will shed light on our 
understanding of allergic response and potentiate interventions. 
Although phosphatidylserine (PS) confined to the inner leaflets of plasma membrane is exposed on the cell 
surface when cells undergo apoptosis, viable cells also externalize PS in certain cellular states. However, the 
pathophysiological significance of PS exposure on viable cells remains elusive. Interestingly, an ITIM-bearing 
inhibitory receptor CD300a is highly expressed by MCs. Intriguingly, the physiological ligands of CD300a is PS. 
Therefore, MCs PS exposure during degranulation and its CD300a expression provide a unique scenario to 
investigate the pathophysiological function of live cell exposed PS in the context of mast cell activation and allergic 
response.  
Purpose: To investigate the role of exposed PS during MCs degranulation in the perspective of an inhibitory receptor 
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 CD300a. 
Results: Through imaging analyses of cultured bone marrow derived MCs (BMMCs) and human synovial mast cells 
(hMCs), the applicant found that PS was exposed on the plasma membrane of live MCs during degranulation within 
minutes after FcεRI stimulation. The PS exposure can be observed in all degranulating stimulations (e.g. ATP and 
ionomycin) but not in non-degranulating stimulation (e.g. LPS and IL-33). In addition, the exposed PS accumulated 
on the cell surface and polarized together with FcεRI as well as degranulation marker CD107a, suggesting that PS 
exposure on live MCs is a degranulation associated event.  
Unlike PS exposed on apoptotic cells, the exposed PS on live MCs did not confer phagocytes engulfment by 
thioglycollate-elicited peritoneal macrophages, although the exposure lasted for hours on live MCs. Surprisingly, the 
applicant found that the externalized PS colocalized with CD300a, an inhibitory immunoreceptor that recognizes PS 
as its natural ligand. Fluorescence resonance energy transfer (FRET) experiment using a fluorescence PS probe and 
a non-blocking anti-CD300a antibody revealed the direct cis-binding between CD300a and PS during degranulation 
in situ. Functionally, the applicant observed that degranulation was greater after stimulation with an IgE–antigen 
complex in MCs deficient in CD300a than in wild-type MCs by comparing the degranulation of BMMCs from both 
wild type and Cd300a-/- mice. Pretreatment of MCs with a neutralizing anti-CD300a antibody efficiently upregulated 
the degranulation of wild-type MCs as a result of interference of cis-interaction between CD300a and PS as evidenced 
by decreased FRET efficiency. Moreover, western analysis indicated the phosphorylation of Syk, an important kinase 
downstream of FcεRI signaling, was strongly enhanced in Cd300a-/- than in wildtype BMMCs. These results indicate 
the presence of cis-interaction between CD300a and externalized PS on degranulating MCs as well as the suppressive 
functions of such interaction during MCs degranulation.  
Consistently, CD300a-deficient mice or in vivo treatment with a neutralizing CD300a antibody showed 
slower recovery of body temperature compared with wild-type mice in a model of MCs-dependent passive systemic 
anaphylaxis (PSA). Importantly, in this PSA model, the ligand of CD300a, namely PS, was exposed and polarized 
on scattered tissue MCs themselves but not surrounding cells. These observations suggest that the cis-interaction 
between CD300a and PS on live MCs also happens in vivo and has potential to suppress the allergic response. 
Discussion: In this study, the applicant found the function of live MCs exposed PS as a suppressive reagent of MCs 
degranulation through its cis-binding with the inhibitory receptor CD300a. By live imaging and imaging flow 
cytometry analysis of MCs degranulation, this study provides the detailed characterization of PS exposure of 
activated MCs. Distinct from apoptotic PS exposure takes hours to occur, degranulated MCs exposed their PS in 
minutes-scale.  Interestingly, although it is clear that the PS exposure on MCs is a degranulation associated event, 
the exact organelle source of surface PS is intriguing, giving that PS+ area contained both patches-like and dot-like 
PS+ regions. This suggests that the externalized PS may come from different source (e.g. inner leaflet of plasma 
membrane, membrane of granules and granule itself).  
Importantly, the externalized PS binds to its receptor CD300a and effectively suppressed the degranulation 
of the same cell, resulting in less degranulated MCs in vitro and better recovery of mice from systemic anaphylaxis 
in vivo. Given the rich inflammatory mediator and protease content released after MCs degranulation, MCs activation 
is a strong immunogenic and maybe disruptive process, therefore should be extensively controlled. However, MCs 
distribute in the tissue in a scattered manner and the ligands of its receptors may not be always available, therefore 
 such self-regulatory characteristic of MCs represents a novel strategy that MCs evolved to control their own 
activation. 
In summary, the applicant suggests an autonomous regulation of MC degranulation through cis-interaction 
of PS with CD300a to down regulate allergic response, adding another layer of regulation in allergic responses. 
 
 
審査の要旨 
 Abstract of assessment result 
 
【批評 Review】 
 
The applicant investigated the role of PS exposed on the plasma membrane of MCs during degranulation. 
He found that a PS receptor CD300a bound to the PS on MCs and autonomously regulated the degranulation by 
suppression of an activating signal mediated by FceRI. These results are extremely novel and important findings in 
cell biology as well as immunology and shed light on a new therapeutic approach to the treatment for allergic diseases.  
 
【最終試験の結果 Result】 
The final examination committee conducted a meeting as a final examination on 3 June, 2019. The applicant 
provided an overview of dissertation, addressed questions and comments raised during Q&A session. All of the 
committee members reached a final decision that the applicant has passed the final examination. 
 
【結論 Conclusion】 
Therefore, the final examination committee approved that the applicant is qualified to be awarded a Doctor 
of Philosophy in Human Biology. 
 
